系统性红斑狼疮中较低维生素D与代谢综合征及胰岛素抵抗相关:来自国际起始队列的数据
该研究基于SLICC国际起始队列,纳入1847例新诊断SLE患者,其中1163例有维生素D测量数据。结果显示,较低25(OH)D水平与代谢综合征及更高HOMA-IR相关,代谢综合征组分高血压、高甘油三酯血症和低HDL均与较低25(OH)D显著相关。
要点
- SLE患者中较低25(OH)D与代谢综合征及胰岛素抵抗相关。
- 代谢综合征组分高血压、高甘油三酯血症和低HDL与较低25(OH)D显著相关。
- 平均糖皮质激素暴露增加与更高胰岛素抵抗相关。
核心结论
- 在SLE患者中,代谢综合征和胰岛素抵抗与较低维生素D水平相关。
研究设计与样本
- SLICC国际起始队列自2000年起从11个国家33个中心纳入新诊断SLE患者(<15个月),收集临床、实验室和治疗数据。
- 维生素D水平按队列分布三分位定义:T1(10-36 nmol/l)、T2(37-60 nmol/l)、T3(61-174 nmol/l)。
- 代谢综合征按2009年国际糖尿病联盟共识定义,胰岛素抵抗采用HOMA-IR模型确定。
- 采用线性和逻辑回归评估变量与维生素D水平的关联。
主要发现
- 1847例患者中1163例(63%)有维生素D测量,398例(34.2%)处于最低25(OH)D三分位。
- 860例可判定代谢综合征状态的患者中286例(33%)存在代谢综合征。
- 较低25(OH)D患者更可能有代谢综合征和更高HOMA-IR。
- 代谢综合征组分高血压、高甘油三酯血症和低HDL均与较低25(OH)D显著相关。
- 平均糖皮质激素暴露增加与更高胰岛素抵抗相关。
关键数值与推荐
- 维生素D三分位:T1(10-36 nmol/l)、T2(37-60 nmol/l)、T3(61-174 nmol/l)。
- 代谢综合征定义依据2009年国际糖尿病联盟共识声明。
- 胰岛素抵抗采用HOMA-IR模型判定。
临床怎么用
- 在SLE患者中评估维生素D水平可能有助于识别代谢综合征和胰岛素抵抗风险较高的个体。
- 对于较低25(OH)D的SLE患者,应关注代谢综合征组分(高血压、高甘油三酯血症、低HDL)的筛查。
- 糖皮质激素暴露增加与胰岛素抵抗相关,临床需注意监测。
局限性
- 维生素D仅在63%的患者中测量,可能存在选择偏倚。
- 代谢综合征状态仅在860例患者中可判定。
- 原文未报告研究设计类型为横断面或纵向分析的具体说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance. METHODS: The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently diagnosed with SLE (<15 months) from 33 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D level was defined according to tertiles based on distribution across this cohort, which were set at T1 (10-36 nmol/l), T2 (37-60 nmol/l) and T3 (61-174 nmol/l). MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Insulin resistance was determined using the HOMA-IR model. Linear and logistic regressions were used to assess the association of variables with vitamin D levels. RESULTS: Of the 1847 patients, 1163 (63%) had vitamin D measured and 398 (34.2%) subjects were in the lowest 25(OH)D tertile. MetS was present in 286 of 860 (33%) patients whose status could be determined. Patients with lower 25(OH)D were more likely to have MetS and higher HOMA-IR. The MetS components, hypertension, hypertriglyceridemia and decreased high-density lipoprotein (HDL) were all significantly associated with lower 25(OH)D. Increased average glucocorticoid exposure was associated with higher insulin resistance. CONCLUSIONS: MetS and insulin resistance are associated with lower vitamin D in patients with SLE. Further studies could determine whether vitamin D repletion confers better control of these cardiovascular risk factors and improve long-term outcomes in SLE.
引用
- Chew C, Reynolds JA, Lertratanakul A, et al. Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort. Rheumatology (Oxford). 2021. PMID: 33555325. doi:10.1093/rheumatology/keab090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。